HD Biosciences Co., Ltd. a WuXi AppTec company, is a biology-focused preclinical drug discovery contract research organization (CRO) with operation facilities in Shanghai, China, San Diego, California, and Cranbury, New Jersey. The company offers comprehensive service platforms around target validation, plate-based pharmacology, hit identification and lead discovery, in vivo pharmacology, as well as other research and development services. The company currently collaborates with global pharmaceutical and biotechnology companies, and has established strategic partnership in many key R&D areas with the impacts to client’s portfolio development. The strong scientific expertise, high quality and consistent deliveries, which constantly meet or exceed client’s expectations, have earned the company a great reputation in the industry and helped the company to build its widely recognized leadership in preclinical contract research services.